Adenocarcinoma of the salivary gland? A chemo-sensitive disease.
Identifieur interne : 003B91 ( PubMed/Checkpoint ); précédent : 003B90; suivant : 003B92Adenocarcinoma of the salivary gland? A chemo-sensitive disease.
Auteurs : J D White ; E J Junor ; J. Mcgarva ; J. Mcmanners ; I S HollandSource :
- Clinical oncology (Royal College of Radiologists (Great Britain)) [ 0936-6555 ] ; 2004.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Adénocarcinome (), Adénocarcinome (anatomopathologie), Adénocarcinome (traitement médicamenteux), Cisplatine (administration et posologie), Fluorouracil (administration et posologie), Hirudothérapie, Humains, Lymphoedème (), Lymphoedème (étiologie), Mâle, Protocoles de polychimiothérapie antinéoplasique (administration et posologie), Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique), Radiothérapie adjuvante, Soins palliatifs, Tumeurs des glandes salivaires (), Tumeurs des glandes salivaires (anatomopathologie), Tumeurs des glandes salivaires (traitement médicamenteux), Épirubicine (administration et posologie).
- MESH :
- administration et posologie : Cisplatine, Fluorouracil, Protocoles de polychimiothérapie antinéoplasique, Épirubicine.
- anatomopathologie : Adénocarcinome, Tumeurs des glandes salivaires.
- traitement médicamenteux : Adénocarcinome, Tumeurs des glandes salivaires.
- usage thérapeutique : Protocoles de polychimiothérapie antinéoplasique.
- étiologie : Lymphoedème.
- Adulte d'âge moyen, Adénocarcinome, Hirudothérapie, Humains, Lymphoedème, Mâle, Radiothérapie adjuvante, Soins palliatifs, Tumeurs des glandes salivaires.
English descriptors
- KwdEn :
- Adenocarcinoma (drug therapy), Adenocarcinoma (pathology), Adenocarcinoma (surgery), Antineoplastic Combined Chemotherapy Protocols (administration & dosage), Antineoplastic Combined Chemotherapy Protocols (therapeutic use), Cisplatin (administration & dosage), Epirubicin (administration & dosage), Fluorouracil (administration & dosage), Humans, Leeching, Lymphedema (etiology), Lymphedema (therapy), Male, Middle Aged, Palliative Care, Radiotherapy, Adjuvant, Salivary Gland Neoplasms (drug therapy), Salivary Gland Neoplasms (pathology), Salivary Gland Neoplasms (surgery).
- MESH :
- chemical , administration & dosage : Cisplatin, Epirubicin, Fluorouracil.
- administration & dosage : Antineoplastic Combined Chemotherapy Protocols.
- drug therapy : Adenocarcinoma, Salivary Gland Neoplasms.
- etiology : Lymphedema.
- pathology : Adenocarcinoma, Salivary Gland Neoplasms.
- surgery : Adenocarcinoma, Salivary Gland Neoplasms.
- therapeutic use : Antineoplastic Combined Chemotherapy Protocols.
- therapy : Lymphedema.
- Humans, Leeching, Male, Middle Aged, Palliative Care, Radiotherapy, Adjuvant.
PubMed: 15074745
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15074745Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Adenocarcinoma of the salivary gland? A chemo-sensitive disease.</title><author><name sortKey="White, J D" sort="White, J D" uniqKey="White J" first="J D" last="White">J D White</name></author><author><name sortKey="Junor, E J" sort="Junor, E J" uniqKey="Junor E" first="E J" last="Junor">E J Junor</name></author><author><name sortKey="Mcgarva, J" sort="Mcgarva, J" uniqKey="Mcgarva J" first="J" last="Mcgarva">J. Mcgarva</name></author><author><name sortKey="Mcmanners, J" sort="Mcmanners, J" uniqKey="Mcmanners J" first="J" last="Mcmanners">J. Mcmanners</name></author><author><name sortKey="Holland, I S" sort="Holland, I S" uniqKey="Holland I" first="I S" last="Holland">I S Holland</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2004">2004</date><idno type="RBID">pubmed:15074745</idno><idno type="pmid">15074745</idno><idno type="wicri:Area/PubMed/Corpus">004030</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004030</idno><idno type="wicri:Area/PubMed/Curation">004030</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004030</idno><idno type="wicri:Area/PubMed/Checkpoint">004030</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004030</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Adenocarcinoma of the salivary gland? A chemo-sensitive disease.</title><author><name sortKey="White, J D" sort="White, J D" uniqKey="White J" first="J D" last="White">J D White</name></author><author><name sortKey="Junor, E J" sort="Junor, E J" uniqKey="Junor E" first="E J" last="Junor">E J Junor</name></author><author><name sortKey="Mcgarva, J" sort="Mcgarva, J" uniqKey="Mcgarva J" first="J" last="Mcgarva">J. Mcgarva</name></author><author><name sortKey="Mcmanners, J" sort="Mcmanners, J" uniqKey="Mcmanners J" first="J" last="Mcmanners">J. Mcmanners</name></author><author><name sortKey="Holland, I S" sort="Holland, I S" uniqKey="Holland I" first="I S" last="Holland">I S Holland</name></author></analytic><series><title level="j">Clinical oncology (Royal College of Radiologists (Great Britain))</title><idno type="ISSN">0936-6555</idno><imprint><date when="2004" type="published">2004</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adenocarcinoma (drug therapy)</term><term>Adenocarcinoma (pathology)</term><term>Adenocarcinoma (surgery)</term><term>Antineoplastic Combined Chemotherapy Protocols (administration & dosage)</term><term>Antineoplastic Combined Chemotherapy Protocols (therapeutic use)</term><term>Cisplatin (administration & dosage)</term><term>Epirubicin (administration & dosage)</term><term>Fluorouracil (administration & dosage)</term><term>Humans</term><term>Leeching</term><term>Lymphedema (etiology)</term><term>Lymphedema (therapy)</term><term>Male</term><term>Middle Aged</term><term>Palliative Care</term><term>Radiotherapy, Adjuvant</term><term>Salivary Gland Neoplasms (drug therapy)</term><term>Salivary Gland Neoplasms (pathology)</term><term>Salivary Gland Neoplasms (surgery)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Adénocarcinome ()</term><term>Adénocarcinome (anatomopathologie)</term><term>Adénocarcinome (traitement médicamenteux)</term><term>Cisplatine (administration et posologie)</term><term>Fluorouracil (administration et posologie)</term><term>Hirudothérapie</term><term>Humains</term><term>Lymphoedème ()</term><term>Lymphoedème (étiologie)</term><term>Mâle</term><term>Protocoles de polychimiothérapie antinéoplasique (administration et posologie)</term><term>Protocoles de polychimiothérapie antinéoplasique (usage thérapeutique)</term><term>Radiothérapie adjuvante</term><term>Soins palliatifs</term><term>Tumeurs des glandes salivaires ()</term><term>Tumeurs des glandes salivaires (anatomopathologie)</term><term>Tumeurs des glandes salivaires (traitement médicamenteux)</term><term>Épirubicine (administration et posologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Cisplatin</term><term>Epirubicin</term><term>Fluorouracil</term></keywords><keywords scheme="MESH" qualifier="administration & dosage" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Cisplatine</term><term>Fluorouracil</term><term>Protocoles de polychimiothérapie antinéoplasique</term><term>Épirubicine</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Adénocarcinome</term><term>Tumeurs des glandes salivaires</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Adenocarcinoma</term><term>Salivary Gland Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Adenocarcinoma</term><term>Salivary Gland Neoplasms</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Adenocarcinoma</term><term>Salivary Gland Neoplasms</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Antineoplastic Combined Chemotherapy Protocols</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Adénocarcinome</term><term>Tumeurs des glandes salivaires</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Protocoles de polychimiothérapie antinéoplasique</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Leeching</term><term>Male</term><term>Middle Aged</term><term>Palliative Care</term><term>Radiotherapy, Adjuvant</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Adénocarcinome</term><term>Hirudothérapie</term><term>Humains</term><term>Lymphoedème</term><term>Mâle</term><term>Radiothérapie adjuvante</term><term>Soins palliatifs</term><term>Tumeurs des glandes salivaires</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15074745</PMID><DateCreated><Year>2004</Year><Month>04</Month><Day>12</Day></DateCreated><DateCompleted><Year>2004</Year><Month>06</Month><Day>15</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0936-6555</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2004</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Clinical oncology (Royal College of Radiologists (Great Britain))</Title><ISOAbbreviation>Clin Oncol (R Coll Radiol)</ISOAbbreviation></Journal><ArticleTitle>Adenocarcinoma of the salivary gland? A chemo-sensitive disease.</ArticleTitle><Pagination><MedlinePgn>159-60</MedlinePgn></Pagination><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>White</LastName><ForeName>J D</ForeName><Initials>JD</Initials></Author><Author ValidYN="Y"><LastName>Junor</LastName><ForeName>E J</ForeName><Initials>EJ</Initials></Author><Author ValidYN="Y"><LastName>McGarva</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>McManners</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Holland</LastName><ForeName>I S</ForeName><Initials>IS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Oncol (R Coll Radiol)</MedlineTA><NlmUniqueID>9002902</NlmUniqueID><ISSNLinking>0936-6555</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>3Z8479ZZ5X</RegistryNumber><NameOfSubstance UI="D015251">Epirubicin</NameOfSubstance></Chemical><Chemical><RegistryNumber>Q20Q21Q62J</RegistryNumber><NameOfSubstance UI="D002945">Cisplatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>U3P01618RT</RegistryNumber><NameOfSubstance UI="D005472">Fluorouracil</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Protocol" UI="C080222">FPEPIR regimen</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="N">Adenocarcinoma</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000971" MajorTopicYN="N">Antineoplastic Combined Chemotherapy Protocols</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002945" MajorTopicYN="N">Cisplatin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015251" MajorTopicYN="N">Epirubicin</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005472" MajorTopicYN="N">Fluorouracil</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D024763" MajorTopicYN="Y">Leeching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010166" MajorTopicYN="N">Palliative Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018714" MajorTopicYN="N">Radiotherapy, Adjuvant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012468" MajorTopicYN="N">Salivary Gland Neoplasms</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2004</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>6</Month><Day>16</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2004</Year><Month>4</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">15074745</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list></list><tree><noCountry><name sortKey="Holland, I S" sort="Holland, I S" uniqKey="Holland I" first="I S" last="Holland">I S Holland</name><name sortKey="Junor, E J" sort="Junor, E J" uniqKey="Junor E" first="E J" last="Junor">E J Junor</name><name sortKey="Mcgarva, J" sort="Mcgarva, J" uniqKey="Mcgarva J" first="J" last="Mcgarva">J. Mcgarva</name><name sortKey="Mcmanners, J" sort="Mcmanners, J" uniqKey="Mcmanners J" first="J" last="Mcmanners">J. Mcmanners</name><name sortKey="White, J D" sort="White, J D" uniqKey="White J" first="J D" last="White">J D White</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003B91 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 003B91 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Checkpoint
|type= RBID
|clé= pubmed:15074745
|texte= Adenocarcinoma of the salivary gland? A chemo-sensitive disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15074745" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |